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Implementation activities for a chemically-defined media platform to 
minimize media variability impact to cell culture performance and product 
quality  
 
Martin Gawlitzek, Brian Wong, Robert Shawley, Masaru Shiratori 
 
Chemically-defined media have been developed for CHO cell culture platform 
processes. During implementation of the media at multiple scales and sites 
globally, additional activities were required to seamlessly balance practical 
considerations with desired process and product quality performance. Three 
main focus areas were further investigated and optimized to enable the platform 
implementation: 1) media preparation, filtration, and post-filtration stability; 2) 
media and supplement viral barrier compatibility; and 3) and raw material 
variability considerations. Overall, the effort provided an outlined approach for 
media implementation in the global network including scale and site-specific case 
studies where novel options were required. 
 
The data generated supported successful implementation of chemically-defined 
platform media at different global sites within our network. Manufacturing-scale 
media preparations met acceptance criteria and resulted in comparable cell 
culture performance and product quality to controls. Practical challenges were 
identified and risk mitigation efforts initiated. The challenges were primarily 
related to poorly-defined media preparation mixing environments as a result of 
variable equipment availability and use. Filtration capacity acceptance criteria 
were met in the scale-down model and large-scale filtration events were 
successful. HTST-compatibility studies showed that HTST-treated media 
performed comparably to control media in cell culture performance and product 
quality. Post-filtration media stability investigations led to the identification of key 
risk factors including temperature and agitation variation during storage, 
nucleation and media destabilization as a result of specific handling practices, 
and the impact of specific process-contacting materials. Options for mitigating the 
media stability risks and enabling successful implementation were developed and 
showed no negative impact for the application. Finally, platform media 
modifications were developed to mitigate raw material variation and product 
quality challenges. The overall evolution of the media platform to ensure flexibility 
and successful implementation will be summarized. 
 
 
